Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT01646060 Completed - Healthy Clinical Trials

Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw

Start date: November 2011
Phase: Phase 1
Study type: Interventional

Zynex's blood volume monitor (BVM) is a non-invasive monitoring device to monitor blood volume and blood loss of a patient during surgery, post operatively and/or in recovery. This monitoring device will identify baseline blood volume and relative changes in blood volume using a specific algorithm to compare and review data already monitored during surgery, displaying blood volume and blood loss in real-time.

NCT ID: NCT01643135 Completed - Bleeding Clinical Trials

Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid

Start date: June 2012
Phase: Phase 4
Study type: Interventional

Tranexamic acid has benn widely used to reduce perioperative bleeding in several operations such as cardiac surgery, liver transplant and joint arthroplasty with good results. Few studies in laminectomy had conflicting results and varying in doses. The objective is to compare perioperative bleeding in major laminectomy between patients receive doubles doses of tranexamic acids (15 mg/kg and 15 mg/kg) with who receive pacebo (0.9% NaCl).

NCT ID: NCT01639833 Completed - Hemorrhage Clinical Trials

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Start date: August 2012
Phase: N/A
Study type: Interventional

The objective of this study is to assess the safety and effectiveness of Veriset™ Hemostatic Patch in cardiovascular procedures by comparing Veriset™ Hemostatic Patch to TachoSil® in subjects undergoing open cardiovascular surgery involving the aorta (e.g., aortic valve replacement (AVR), David procedure, Bentall procedure, abdominal aortic aneurysm repair, etc.), or CABG.

NCT ID: NCT01629381 Completed - Clinical trials for Venous Thromboembolism

Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy

ERIKA
Start date: May 2012
Phase: Phase 2
Study type: Interventional

Study Objective: To assess the value of Rivaroxaban for the prevention of venous thromboembolism (VTE) after knee arthroscopy (KA) taking the placebo as standard of reference. Study Population: Patients undergoing therapeutic KA at the study Centers, irrespective of the type and duration of the procedure, will be eligible for the study. Study Design: Multicenter, randomized, double blind superiority, phase II trial comparing two arms: - (R-7d) Rivaroxaban (10 mg od os) for 7 days - (PL-7d) Placebo for 7 days. Follow-up: 3-month period after the randomization Standard of Reference:Placebo will be the standard of reference in accordance to international guidelines Study length May 2012-December 2012 Total patients number: 500 patients Primary Efficacy End-Point: Occurrence in the 3-month period after the randomization of at least one of the following events, objectively proven (by means of CCDU; multi-slice chest TC-angio; autopsy, if necessary, or clinical ground): - All-cause mortality - Symptomatic VTE - Asymptomatic proximal DVT Secondary Efficacy End-point: • Combined incidence of all DVT plus symptomatic PE Primary Safety End-point: Incidence of major bleedings. Secondary Safety End-point: Overall incidence of bleeding

NCT ID: NCT01625585 Completed - Clinical trials for Obscure Gastrointestinal Bleeding

Single Balloon Enterosocpy Obscure Gastrointestinal Bleeding Bleed

Start date: May 2011
Phase: N/A
Study type: Observational

The goal of the present study is to investigate the clinical outcomes of patients with gastrointestinal bleeding originating from the small intestine following diagnostic investigation with single balloon enteroscopy. We hypothesize that single balloon enteroscopy can arrive at a diagnosis and provide therapeutics in a majority of patients with gastrointestinal bleeding originating in the small intestine.

NCT ID: NCT01623206 Completed - Colorectal Cancer Clinical Trials

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Start date: April 2013
Phase: Phase 2
Study type: Interventional

The objective of this study is to find the maximum tolerated dose and preliminary efficacy of desmopressin as an haemostatic agent, when is administered to patients with colorectal cancer and rectal bleeding, before specific oncologic treatment with surgery and/or chemotherapy and/or radiotherapy.

NCT ID: NCT01622946 Completed - Clinical trials for Total Hip Arthroplasty

The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach

Start date: April 2012
Phase: Phase 4
Study type: Interventional

The effects of topical application of 3g tranexamic acid for 2 hours prior to opening of the suction drain following a total hip replacement

NCT ID: NCT01620203 Completed - Clinical trials for Intraventricular Hemorrhage

Observational Study in Preterm Infants With Intracranial Hemorrhage

Start date: June 2012
Phase:
Study type: Observational

Intracranial Hemorrhage (ICH) is an important morbidity affecting premature infants and can have considerable effects on neurodevelopmental outcome. The investigators showed that preterm infants with severe ICH have decreased cerebral oxygenation several weeks after the hemorrhage. The mechanisms involved in this state of decreased cerebral oxygenation in preterm infants and the effects on cerebral function are unknown. This longitudinal observation study will evaluate physiologic parameters to determine trends in cerebral oxygenation and function in preterm infants with ICH in comparison to infants without ICH.

NCT ID: NCT01619709 Completed - Clinical trials for Intracerebral Hemorrhage

Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

COGHIC-AV45
Start date: January 2012
Phase: N/A
Study type: Interventional

To evaluate Pet AV-45 Amyloid imaging in the etiological diagnosis of primary non traumatic intracerebral hemorrhage (Cerebral Amyloid Angiopathy and hypertension related hemorrhage).We hypothesize that patients with lobar hemorrhage (probably related to Cerebral Amyloid Angiopathy) will have a greater AV45 cortical binding than patients with deep hemorrhage (probably related to hypertension).

NCT ID: NCT01619072 Completed - Clinical trials for Postpartum Hemorrhage

Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in Egypt

Start date: November 2012
Phase: N/A
Study type: Interventional

This randomized controlled community-based trial will assess the effectiveness of administration of 800 mcg sublingual misoprostol with standard of care vs. placebo with standard of care for postpartum hemorrhage treatment at the community level, primarily home births attended by primary health care unit (PHU) staff in Etay El Barood and Kafr El Dawar districts (El Beheira governorate), Egypt. Standard of care per national guidelines in this setting is referral to a higher level health facility.